Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...

Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...

In the scientific community, a lab’s location can be critical to its overall success. Historically, the majority of UK life science investment happened inside the ‘golden triangle’, but the tide is ...

Triangle school systems will remain closed on Thursday as the area digs out from the latest winter storm. All Triangle school systems closed their schools on Wednesday due to the inclement weather.

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Ah, the Bermuda Triangle, a place that has managed to provide an equal source of fascination and fear. If the urban legends are to be believed, the Bermuda Triangle should be a no-go zone (Getty ...

For a list of Thursday closings and delays, see this story. Triangle schools will be closed Wednesday due to the threat of snowy weather Several school districts that had planned to have a two ...

The team trained a machine-learning algorithm to analyse the text of the papers and classify the research according to scientific categories laid out by the NIH, such as ‘chronic pain’ or ...

The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.

Credit: Shutterstock / Good dreams – Studio US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal atrial ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $110.00. The company’s shares closed ...